Supernus (INDV) EBT Margin (2024 - 2026)
Indivior Pharmaceuticals' EBT Margin was 51.12% in Q3 2026, up 39.34 percentage points from 11.78% a year earlier and up 4.48 percentage points from the prior quarter.
Powered by 
Analysis
Supernus (INDV) EBT Margin (2024 - 2026) Analysis & Trends
On a trailing twelve-month basis, Indivior Pharmaceuticals' EBT Margin was 39.16% through Sep 30, 2026, up 22.56 percentage points year-over-year; for FY2025, it was 19.29%, up 17.61 percentage points from FY2024.
- EBT Margin shows a four-year change of -4.73 percentage points (FY2021 to FY2025).
- In earlier years, EBT Margin was 1.68% in FY2024 (+14.95 pp), -13.27% in FY2023 (-3.72 pp), -9.54% in FY2022 (-33.57 pp) and 24.02% in FY2021.
- The Q3 2026 figure marks the highest quarterly EBT Margin in data going back to Q1 2024.
- Compared with a year earlier, EBT Margin has increased for six straight quarters, with an average year-over-year change of +21.28 percentage points over the last seven quarters.
- Per Business Quant data, INDV's EBT Margin in the three quarters before Q3 2026 was 46.65% (Q2 2026), 36.28% (Q1 2026) and 22.63% (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 34.46% |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 0.13% |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 27.75% |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 30.74% |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 29.63% |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 18.19% |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 45.21% |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 36.90% |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 20.41% |
| 10 | Supernus | 4.28 Bn | 3.38 Bn | 305.00 Mn | 51.12% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 51.12% |
| Jun 30, 2026 | 46.65% |
| Mar 31, 2026 | 36.28% |
| Dec 31, 2025 | 22.63% |
| Sep 30, 2025 | 11.78% |
| Jun 30, 2025 | 20.53% |
| Mar 31, 2025 | 22.18% |
| Dec 31, 2024 | 12.71% |
| Sep 30, 2024 | 9.77% |
| Jun 30, 2024 | -40.47% |
| Mar 31, 2024 | 25.70% |
API Access
Supernus EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=INDV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "INDV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=INDV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();